A

$A

Agilent Technologies

Life sciences instruments, diagnostics, and applied chemical markets.

Healthcare
Subscribers
0
Tracking this ticker
Latest Report

Analysis from Apr 6, 2026

A: Agilent — Growth with Legal Headwinds

Agilent ($A) shows strong fundamentals and analyst support, but a Supreme Court setback on CRISPR patents and recent share weakness temper upside. This note breaks down valuation, catalysts, risks and what to watch ahead of Q2 2026 earnings.

Apr 6, 2026
Read Report

Previous Reports

A (Agilent) — FDA Win Meets Valuation Check

Mar 30, 2026

A: Agilent — Valuation Reset, Precision Oncology Upside

Mar 22, 2026

A: Agilent Technologies — Growth vs Valuation

Mar 16, 2026

Explore More Content